These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3249905)

  • 1. [Adverse effect of the intermittent use of rifampicin in treating Hansen's disease].
    Papaiordanou PM; Branchini ML; Gonçales Júnior FL; Aoki FH; Boccato RS; Ramos Mde C; Pedro RJ
    Rev Inst Med Trop Sao Paulo; 1988; 30(5):383-6. PubMed ID: 3249905
    [No Abstract]   [Full Text] [Related]  

  • 2. Intravascular haemolysis and renal failure caused by intermittent rifampicin treatment.
    Criel A; Verwilghen RL
    Blut; 1980 Feb; 40(2):147-50. PubMed ID: 7353082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of acute renal failure after intermittent rifampicin therapy].
    Fukunishi Y; Imaizumi M; Imagawa A; Yamashita T
    Nihon Rai Gakkai Zasshi; 1984; 53(4):193-9. PubMed ID: 6536642
    [No Abstract]   [Full Text] [Related]  

  • 4. Adverse reactions to rifampicin in antituberculosis regimens.
    Girling DJ
    J Antimicrob Chemother; 1977 Mar; 3(2):115-32. PubMed ID: 324964
    [No Abstract]   [Full Text] [Related]  

  • 5. Agranulocytosis induced by multidrug therapy in leprosy treatment: a case report.
    Silva IM; Oliveira CA; Guedes WR; Oliveira BB; Oliveira DA; Guedes Filho G
    Braz J Infect Dis; 2009 Apr; 13(2):158-60. PubMed ID: 20140364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A fatal case of drug-induced multi-organ damage in a patient with Hansen's disease: dapsone syndrome or rifampicin toxicity?
    Lau G
    Forensic Sci Int; 1995 May; 73(2):109-15. PubMed ID: 7797183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Severe complications following intermittent administration of rifampicin].
    Manasia M; Paul G; Maniţiu PI
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(3):183-8. PubMed ID: 188103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravascular hemolysis and acute renal failure following intermittent rifampin therapy.
    Gupta A; Sakhuja V; Gupta KL; Chugh KS
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):185-8. PubMed ID: 1522360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure due to rifampicin: a study of 25 patients.
    Muthukumar T; Jayakumar M; Fernando EM; Muthusethupathi MA
    Am J Kidney Dis; 2002 Oct; 40(4):690-6. PubMed ID: 12324902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
    Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S
    South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
    [No Abstract]   [Full Text] [Related]  

  • 11. Hemolytic anemia in patients receiving daily dapsone for the treatment of leprosy.
    Deps P; Guerra P; Nasser S; Simon M
    Lepr Rev; 2012 Sep; 83(3):305-7. PubMed ID: 23356031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hematological abnormalities during treatment with rifampicin].
    Lebacq E; Taminau E
    Lille Med; 1974 Mar; 19(3):269-71. PubMed ID: 4437277
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features.
    De Vriese AS; Robbrecht DL; Vanholder RC; Vogelaers DP; Lameire NH
    Am J Kidney Dis; 1998 Jan; 31(1):108-15. PubMed ID: 9428460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute renal failure and severe thrombocytopenia induced by rifampicin: report of a case.
    Juang YC; Tsao TC; Chiang YC; Lin JL; Tsai YH
    J Formos Med Assoc; 1992 Apr; 91(4):475-6. PubMed ID: 1358323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe thrombocytopenia and intermittent use of rifampin.
    Nishioka SA; Goulart IM; Nunes-Araújo FR; Arantes SC; Burgarelli MK; Ferreira MS; dos Santos RP; Lopes VR
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):273-4. PubMed ID: 1522369
    [No Abstract]   [Full Text] [Related]  

  • 16. Potentially serious side effects of high-dose twice-weekly rifampicin.
    Poole G; Stradling P; Worlledge S
    Br Med J; 1971 Aug; 3(5770):343-7. PubMed ID: 5314737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal failure and rifampicin: danger of unsuspected intermittent dosage.
    Flynn CT; Rainford DJ; Hope E
    Br Med J; 1974 Jun; 2(5917):482. PubMed ID: 4834101
    [No Abstract]   [Full Text] [Related]  

  • 18. Potentially serious side-effects of high-dose twice-weekly rifampicin.
    Poole G; Stradling P; Worlledge S
    Postgrad Med J; 1971 Nov; 47(553):727-47. PubMed ID: 5159676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal reaction to Hansen's disease.
    Jih MH; Kimyai-Asadi A; Levis WR
    J Drugs Dermatol; 2002 Jul; 1(1):70-1. PubMed ID: 12847760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatorenal failure with self-initiated intermittent rifampicin therapy.
    Rothwell DL; Richmond DE
    Br Med J; 1974 Jun; 2(5917):481-2. PubMed ID: 4834100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.